KBC Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $60.2M | Buy |
278,652
+43,960
| +19% | +$8.41M | 0.13% | 152 |
|
|
2026
Q1 | $43M | Buy |
234,692
+181,294
| +340% | +$33.4M | 0.11% | 171 |
|
|
2025
Q4 | $9.4M | Buy |
53,398
+17,939
| +51% | +$2.93M | 0.02% | 364 |
|
|
2025
Q3 | $4.97M | Buy |
35,459
+255
| +0.7% | +$34.5K | 0.01% | 449 |
|
|
2025
Q2 | $4.42M | Buy |
35,204
+864
| +3% | +$108K | 0.01% | 460 |
|
|
2025
Q1 | $4.7M | Buy |
34,340
+850
| +3% | +$122K | 0.01% | 466 |
|
|
2024
Q4 | $5.12M | Buy |
33,490
+261
| +0.8% | +$44K | 0.01% | 482 |
|
|
2024
Q3 | $6.44M | Sell |
33,229
-8,752
| -21% | -$1.83M | 0.02% | 439 |
|
|
2024
Q2 | $9.73M | Sell |
41,981
-3,526
| -8% | -$766K | 0.03% | 342 |
|
|
2024
Q1 | $9.81M | Sell |
45,507
-5,329
| -10% | -$1.25M | 0.03% | 344 |
|
|
2023
Q4 | $13.2M | Buy |
50,836
+2,358
| +5% | +$579K | 0.05% | 318 |
|
|
2023
Q3 | $12.5M | Sell |
48,478
-23,832
| -33% | -$6.37M | 0.05% | 302 |
|
|
2023
Q2 | $20.6M | Buy |
72,310
+4,891
| +7% | +$1.46M | 0.08% | 214 |
|
|
2023
Q1 | $18.7M | Buy |
67,419
+28,878
| +75% | +$7.99M | 0.08% | 243 |
|
|
2022
Q4 | $10.7M | Buy |
38,541
+8,739
| +29% | +$2.47M | 0.05% | 308 |
|
|
2022
Q3 | $7.96M | Sell |
29,802
-2,394
| -7% | -$508K | 0.04% | 323 |
|
|
2022
Q2 | $6.57M | Sell |
32,196
-1,433
| -4% | -$293K | 0.03% | 356 |
|
|
2022
Q1 | $7.08M | Sell |
33,629
-7,067
| -17% | -$1.54M | 0.03% | 371 |
|
|
2021
Q4 | $9.76M | Sell |
40,696
-5,801
| -12% | -$1.49M | 0.03% | 347 |
|
|
2021
Q3 | $13.2M | Sell |
46,497
-48,763
| -51% | -$16M | 0.05% | 322 |
|
|
2021
Q2 | $33M | Buy |
95,260
+966
| +1% | +$293K | 0.06% | 292 |
|
|
2021
Q1 | $26.4M | Sell |
94,294
-3,878
| -4% | -$1.05M | 0.05% | 327 |
|
|
2020
Q4 | $132M | Sell |
98,172
-84,866
| -46% | -$21.9M | 0.06% | 304 |
|
|
2020
Q3 | $51.9M | Buy |
183,038
+4,590
| +3% | +$1.28M | 0.15% | 155 |
|
|
2020
Q2 | $47.7M | Buy |
178,448
+45,304
| +34% | +$13.6M | 0.16% | 142 |
|
|
2020
Q1 | $42.1M | Sell |
133,144
-10,479
| -7% | -$3.18M | 0.35% | 60 |
|
|
2019
Q4 | $42.6M | Sell |
143,623
-11,623
| -7% | -$3.22M | 0.27% | 87 |
|
|
2019
Q3 | $36.1M | Buy |
155,246
+71,393
| +85% | +$16.6M | 0.27% | 85 |
|
|
2019
Q2 | $19.6M | Buy |
83,853
+2,394
| +3% | +$553K | 0.15% | 172 |
|
|
2019
Q1 | $19.3M | Buy |
81,459
+32,149
| +65% | +$10.1M | 0.16% | 163 |
|
|
2018
Q4 | $14.8M | Sell |
49,310
-19,585
| -28% | -$6.25M | 0.17% | 154 |
|
|
2018
Q3 | $24.3M | Sell |
68,895
-12,463
| -15% | -$4.29M | 0.18% | 142 |
|
|
2018
Q2 | $23.6M | Sell |
81,358
-37,900
| -32% | -$10.7M | 0.21% | 134 |
|
|
2018
Q1 | $32.7M | Sell |
119,258
-3,893
| -3% | -$1.21M | 0.3% | 82 |
|
|
2017
Q4 | $39.2M | Buy |
123,151
+42,703
| +53% | +$13.7M | 0.34% | 74 |
|
|
2017
Q3 | $25.2M | Buy |
80,448
+433
| +0.5% | +$128K | 0.23% | 113 |
|
|
2017
Q2 | $21.7M | Sell |
80,015
-15,982
| -17% | -$4.23M | 0.21% | 131 |
|
|
2017
Q1 | $26.2M | Sell |
95,997
-79,620
| -45% | -$22.5M | 0.24% | 101 |
|
|
2016
Q4 | $49.8M | Buy |
175,617
+19,369
| +12% | +$5.74M | 0.49% | 39 |
|
|
2016
Q3 | $48.9M | Buy |
156,248
+65,472
| +72% | +$19.4M | 0.58% | 32 |
|
|
2016
Q2 | $22M | Buy |
90,776
+267
| +0.3% | +$70.4K | 0.31% | 74 |
|
|
2016
Q1 | $23.6M | Sell |
90,509
-1,088
| -1% | -$287K | 0.39% | 55 |
|
|
2015
Q4 | $28.1M | Buy |
91,597
+5,427
| +6% | +$1.56M | 0.52% | 39 |
|
|
2015
Q3 | $25.1M | Sell |
86,170
-25,637
| -23% | -$8.47M | 0.51% | 36 |
|
|
2015
Q2 | $45.2M | Sell |
111,807
-11,276
| -9% | -$4.53M | 0.58% | 24 |
|
|
2015
Q1 | $52M | Sell |
123,083
-14,952
| -11% | -$5.89M | 0.66% | 21 |
|
|
2014
Q4 | $46.9M | Buy |
138,035
+134,623
| +3,946% | +$43.6M | 0.56% | 30 |
|
|
2014
Q3 | $1.13M | Sell |
3,412
-161,008
| -98% | -$53.1M | 0.04% | 480 |
|
|
2014
Q2 | $51.8M | Buy |
164,420
+54,064
| +49% | +$16.3M | 0.59% | 28 |
|
|
2014
Q1 | $33.8M | Sell |
110,356
-3,960
| -3% | -$1.26M | 0.53% | 38 |
|
|
2013
Q4 | $32M | Sell |
114,316
-4,095
| -3% | -$1.06M | 0.48% | 43 |
|
|
2013
Q3 | $28.5M | Buy |
118,411
+34,180
| +41% | +$7.65M | 0.46% | 42 |
|
|
2013
Q2 | $18.1M | Buy |
+84,231
| New | +$18M | 0.34% | 68 |
|
Other funds holding BIIB
AIM
KBC Group's BIIB Position: Q2 2026 in Review
KBC Group increased its Biogen (BIIB) stake by 19% in Q2 2026, buying an estimated $8.41M and bringing the position to 278,652 shares worth $60.2M. The position accounts for 0.13% of the portfolio, ranked #152.
KBC Group first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $132M in Q4 2020. 569 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- KBC Group held 278,652 shares of Biogen worth $60.2M as of Q2 2026.
- KBC Group bought 43,960 Biogen shares in Q2 2026, an estimated $8.41M.
- Biogen made up 0.13% of KBC Group's portfolio in Q2 2026, its #152 holding.
- KBC Group first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- KBC Group's Biogen position peaked at $132M in Q4 2020.
- 569 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.